findmyKOL
Clinical trialNCT01715350CompletedPhase 2Interventional

Study to Explore the Optimal Dosage/Administration in Alzheimer's Disease

SponsorVTBIO Co. LTDEnrollment151Alzheimer's Disease
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

South Korea
  • Kyung Hee University Oriental Medicine Hospital

    Seoul, Dongdaemun-gu, South Korea

  • National Health Insurance Corporation Ilsan Hospital

    Goyang, Ilsandong-gu, South Korea

  • the Catholic University of Korea, St. Vincent'S Hospital

    Suwon, Paldal-gu, South Korea

  • the Catholic University of Korea, Seoul St. Mary'S Hospital

    Seoul, Seocho-gu, South Korea

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 May 2012
Primary completion
30 Sept 2014
Completion
30 Jun 2015
Last update posted
18 Apr 2016
Registered enrollment
151
Registry id
NCT01715350

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.